Hypogammaglobulinemia and AD were identified in 9 (60%) and 7 (47%) patients with IKAROS deficiency, and 15 (48%) and 24 (77%) patients with CTLA4 deficiency (Figure 4B). Here, CTLA4 is linked to Alzheimer disease.